ANACONDA BIOMED S.L. secures €20 Million round of funding

by Anaconda BioMed

​Anaconda​ Biomed S.L., a medical technology company developing next-generation th​rombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding w...

Read more

Anaconda announces first-in-human study of next-generation thrombectomy system

by CataloniaBio

Anacon​da Biomed, a medical technology company developing a next-generation​ thrombectomy system for the treatment of ischemic stroke, has announced the completion of initial patient cases in a fi...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Theriva™ Biologics to Present Preclini...

by Theriva™ Biologics

Theriva™ Biologics has announced the presentation of preclinical da...

Photos Stream